Gimsilumab (Anti-CSF2 / GM-CSF)
Product Specifications
CAS Number
1648796-29-5
Synonyms
MORAb-022
SKU
C00609-1mg
Target
SARS-CoV
Applications
Microbiology
Additionnal Information
Gimsilumab (Anti-CSF2 / GM-CSF) is a human immunoglobulin G1 (IgG1) monoclonal antibody directed against the myeloid cell growth factor and inflammatory mediator granulocyte-macrophage colony-stimulating factor (GM-CSF) with potential immunomodulating activity. MW : 145.8 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1366575-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator SAB2452 (SAB2452)
Ask
View Details MBS1366575-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator SAB2452 (SAB2452)
Ask
View Details MBS1366575-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator SAB2452 (SAB2452)
Ask
View Details MBS1366575-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator SAB2452 (SAB2452)
Ask
View Details MBS1366575-05 0.02 mg (Baculovirus)
Recombinant Staphylococcus aureus HTH-type transcriptional regulator SAB2452 (SAB2452)
Ask
View Details